3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)...

Organic compounds -- part of the class 532-570 series – Organic compounds – Unsubstituted hydrocarbyl chain between the ring and the -c-...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07141667

ABSTRACT:
The present invention relates to a process for preparing the compound 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-one of formulawhich is to be found as a structural element in CGRP-antagonists, which are particularly suitable for the oral treatment of migraine.

REFERENCES:
patent: 3474090 (1969-10-01), Wright, Jr.
patent: 2361939 (2000-09-01), None
patent: 0055154 (2000-09-01), None
Mayer, P. et al; New Substituted 1-(2,3-Dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl Derivatives with a2-Adrenoceptor Antagonist Activity; Journal of Medicinal Chemistry, 2000, vol. 43, pp. 3653-3664.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3623283

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.